Anzeige
Mehr »
Login
Samstag, 25.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Achtung! Ist das die Krypto-Aktie des Jahres 2024 mit 700% Potential?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCWK | ISIN: BE0974358906 | Ticker-Symbol: 5YI
München
24.05.24
15:22 Uhr
8,260 Euro
-1,240
-13,05 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NYXOAH SA Chart 1 Jahr
5-Tage-Chart
NYXOAH SA 5-Tage-Chart
RealtimeGeldBriefZeit
7,6608,02012:28

Aktuelle News zur NYXOAH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrXFRA 5YI: WIEDERAUFNAHME/RESUMPTION39FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
DoNyxoah Announces Pricing of Offering167REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Pricing of Offering Mont-Saint-Guibert, Belgium - May 23, 2024, 3:50 pm CET / 9:50 am ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)...
► Artikel lesen
Do XFRA 5YI: AUSSETZUNG/SUSPENSION193DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNYXOAH S.A. 5YI...
► Artikel lesen
MiNyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program205REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Reduction of the Maximum Amount Available Under its At-the-Market Equity Offering Program Mont-Saint-Guibert, Belgium - May 22, 2024...
► Artikel lesen
MiNyxoah SA - 6-K, Report of foreign issuer2
MiNyxoah Announces Proposed Offering of Ordinary Shares314REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Proposed Offering of Ordinary Shares Mont-Saint-Guibert, Belgium - May 22, 2024, 10:05pm CET / 4:05pm ET - Nyxoah SA (Euronext Brussels/Nasdaq:...
► Artikel lesen
15.05.Nyxoah reports Q1 results3
15.05.Nyxoah SA reports results for the quarter ended in March - Earnings Summary2
14.05.Nyxoah SA - 6-K, Report of foreign issuer1
14.05.Nyxoah Reports First Quarter 2024 Financial and Operating Results308REGULATED INFORMATION Nyxoah Reports First Quarter 2024 Financial and Operating ResultsAnnounced DREAM U.S. pivotal study achieved primary endpoints On track for FDA approval as early as end of...
► Artikel lesen
13.05.Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024169Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024 Mont-Saint-Guibert, Belgium - May 13, 2024, 10:30pm CET / 4:30pm ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah"...
► Artikel lesen
10.05.Nyxoah: Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 12, 2024294REGULATED INFORMATIONMay 10, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the "Company") Invitation to attend...
► Artikel lesen
15.04.Nyxoah SA - 6-K, Report of foreign issuer1
12.04.Nyxoah Appoints Maurits Boon As Chief Medical Officer1
11.04.Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer278Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer Mont-Saint-Guibert, Belgium - April 11, 2024, 10:30pm CET / 4:30pm ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah"...
► Artikel lesen
11.04.Enlivex Therapeutics, Nyxoah SA, China SXT Pharmaceuticals among healthcare movers7
29.03.Nyxoah: Information on the total number of voting rights and shares353REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), March 29, 2024, 9:30 pm CET / 4:30 pm ET - In accordance with article 15...
► Artikel lesen
25.03.Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology - Head & Neck Surgery Foundation199Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology - Head & Neck Surgery FoundationFirst medical device company to become a corporate champion...
► Artikel lesen
20.03.Nyxoah SA - 20-F, Annual and transition report of foreign private issuers2
20.03.Stifel lifts Nyxoah stock target to $27 on trial success2
Seite:  Weiter >>
57 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1